ebomi
Colour theme
Sign in
Insider · CIK 0001290166

QVT Associates GP LLC

CIK 0001290166 Name as filed on the most recent filing

Filed as QVT Associates GP LLC (81)

202 transaction lines · from 81 filings · filed 2009-09-24 to 2019-06-19 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

53 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2019-06-19 P, Open-market purchase Urovant Sciences Ltd.UROV 40,495, acquired Open Form 4 filing 0000899243-19-017480
2019-06-18 P, Open-market purchase Urovant Sciences Ltd.UROV 55,061, acquired Open Form 4 filing 0000899243-19-017480
2019-06-17 P, Open-market purchase Urovant Sciences Ltd.UROV 55,825, acquired Open Form 4 filing 0000899243-19-017480
2019-06-14 P, Open-market purchase Urovant Sciences Ltd.UROV 56,514, acquired Open Form 4 filing 0000899243-19-017094
2019-06-13 P, Open-market purchase Urovant Sciences Ltd.UROV 58,543, acquired Open Form 4 filing 0000899243-19-017094
2019-06-12 P, Open-market purchase Urovant Sciences Ltd.UROV 62,244, acquired Open Form 4 filing 0000899243-19-017094
2019-06-11 P, Open-market purchase Urovant Sciences Ltd.UROV 61,694, acquired Open Form 4 filing 0000899243-19-016511
2019-06-10 P, Open-market purchase Urovant Sciences Ltd.UROV 62,594, acquired Open Form 4 filing 0000899243-19-016511
2019-06-07 P, Open-market purchase Urovant Sciences Ltd.UROV 52,959, acquired Open Form 4 filing 0000899243-19-016511
2019-06-06 P, Open-market purchase Urovant Sciences Ltd.UROV 56,621, acquired Open Form 4 filing 0000899243-19-015910
2019-06-05 P, Open-market purchase Urovant Sciences Ltd.UROV 52,418, acquired Open Form 4 filing 0000899243-19-015910
2019-06-04 P, Open-market purchase Myovant Sciences Ltd.MYOV 19,999,997, acquired Open Form 4 filing 0000899243-19-015895
2019-06-04 P, Open-market purchase Urovant Sciences Ltd.UROV 56,911, acquired Open Form 4 filing 0000899243-19-015910
2019-06-03 P, Open-market purchase Urovant Sciences Ltd.UROV 41,815, acquired Open Form 4 filing 0000899243-19-015402
2019-05-31 P, Open-market purchase Urovant Sciences Ltd.UROV 39,042, acquired Open Form 4 filing 0000899243-19-015402
2019-05-30 P, Open-market purchase Urovant Sciences Ltd.UROV 2 lines 58,090, acquired Open Form 4 filing 0000899243-19-015402
2019-05-29 P, Open-market purchase Urovant Sciences Ltd.UROV 51,983, acquired Open Form 4 filing 0000899243-19-015062
2019-05-28 P, Open-market purchase Urovant Sciences Ltd.UROV 29,245, acquired Open Form 4 filing 0000899243-19-015062
2019-05-24 P, Open-market purchase Urovant Sciences Ltd.UROV 29,233, acquired Open Form 4 filing 0000899243-19-015062
2019-05-23 P, Open-market purchase Urovant Sciences Ltd.UROV 37,252, acquired Open Form 4 filing 0000899243-19-014556
2019-05-22 P, Open-market purchase Urovant Sciences Ltd.UROV 40,558, acquired Open Form 4 filing 0000899243-19-014556
2019-05-21 P, Open-market purchase Urovant Sciences Ltd.UROV 85,108, acquired Open Form 4 filing 0000899243-19-014556
2019-05-20 P, Open-market purchase Urovant Sciences Ltd.UROV 2 lines 80,525, acquired Open Form 4 filing 0000899243-19-014214
2019-05-17 P, Open-market purchase Urovant Sciences Ltd.UROV 45,641, acquired Open Form 4 filing 0000899243-19-014214
2019-05-16 P, Open-market purchase Urovant Sciences Ltd.UROV 36,718, acquired Open Form 4 filing 0000899243-19-014214
2019-03-18 P, Open-market purchase Axovant Sciences Ltd.AXON 10,000,001, acquired Open Form 4 filing 0000899243-19-008356
2018-12-18 P, Open-market purchase Axovant Sciences Ltd.AXON 10,000,000, acquired Open Form 4 filing 0000899243-18-031450
2018-10-01 P, Open-market purchase Urovant Sciences Ltd.UROV 37,499,994, acquired Open Form 4 filing 0000899243-18-026091
2018-06-05 P, Open-market purchase Axovant Sciences Ltd.AXON 25,000,000, acquired Open Form 4 filing 0000899243-18-015353
2018-04-02 P, Open-market purchase Myovant Sciences Ltd.MYOV 22,500,004, acquired Open Form 4 filing 0000899243-18-009452
2015-01-09 S, Open-market sale Agenus IncAGEN 14 lines 12,451,322, disposed Open Form 4 filing 0001209191-15-003951
2014-06-16 S, Open-market sale Achillion Pharmaceuticals IncACHN 7,281,324, disposed Open Form 4 filing 0001209191-14-042349
2014-06-16 S, Open-market sale Achillion Pharmaceuticals IncACHN 3,033,685, disposed Open Form 4 filing 0001209191-14-042349
2014-06-16 S, Open-market sale Achillion Pharmaceuticals IncACHN 1,748,076, disposed Open Form 4 filing 0001209191-14-042349
2014-06-16 S, Open-market sale Achillion Pharmaceuticals IncACHN 1,171,500, disposed Open Form 4 filing 0001209191-14-042349

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
%, Ten percent owner
Ten percent owner

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 17
  • Open-market sale 36
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. QVT Associates GP LLC, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001290166

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.